HKD 6.09
(-1.62%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 7.26 Billion CNY | -18.18% |
2022 | 8.87 Billion CNY | 9.95% |
2021 | 8.07 Billion CNY | 72.19% |
2020 | 4.68 Billion CNY | 0.0% |
2019 | - CNY | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 7.32 Billion CNY | 0.82% |
2023 FY | 7.26 Billion CNY | -18.18% |
2023 Q2 | 8.88 Billion CNY | 0.08% |
2023 Q4 | 7.26 Billion CNY | -18.25% |
2022 Q4 | 8.87 Billion CNY | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Uni-Bio Science Group Limited | 409.99 Million HKD | -1671.253% |
CK Life Sciences Int'l., (Holdings) Inc. | 11.24 Billion HKD | 35.434% |